Page 5 - Guerbet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Guerbet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Guerbet Today - Breaking & Trending Today

Guerbet receives EMA acceptance of Elucirem as the Brand Name for Gadopiclenol

VILLEPINTE, France, June 13, 2022 /PRNewswire/ Guerbet (EuronextParis: GBT) (ISIN: FR0000032526), a global leader in medical imaging, announces today that Elucirem, the proposed Guerbet brand ....

United States , Languedoc Roussillon , Prnewswire Guerbet Euronextparis , David Hale , Guerbet Research Development , European Medicines Agency , Guerbet Group , Chief Executive Officer , Gadopiclenol Centralized Application , Central Nervous System , Magnetic Resonance Imaging , Text View , Body Magnetic Resonance Imaging , Full Text View , Euronext Paris ,

Guerbet: Q1 2022 revenue

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , North Carolina , Languedoc Roussillon , Midi Pyrées , Benjamin Lehari , Jennifer Jullia , Drug Administration , European Medicines Agency , Group Universal Registration Document , Financial Communications , Euronext Paris , Universal Registration Document , Globe Newswire ,

Guerbet: Q1 2022 revenue Seite 1

21.04.2022 - Q1 2022 sales Business growth Sales Increase of 2.7% compared with Q1 2021 (€181.1m)Up 0.5% at constant exchange rates (CER1) 2022 guidance confirmed Villepinte, Thursday, April 21, 2022 – Guerbet (FR0000032526 GBT), a global specialist in . Seite 1 ....

North Carolina , United States , Languedoc Roussillon ,

Gadopiclenol Marketing Authorization dossier submissions accepted for review by EMA and FDA

/PRNewswire/ Guerbet (FR0000032526 GBT), a global leader in medical imaging offering a comprehensive range of pharmaceutical products, medical devices, and. ....

United States , Languedoc Roussillon , Guerbet Research Development , Drug Administration , European Medicine Agency , Priority Review , New Drug Application , Decentralized Application , Marketing Authorization , Central Nervous System , Magnetic Resonance Imaging , Text View , Body Magnetic Resonance Imaging , Full Text View , Euronext Paris ,

Guerbet: 2021 annual results

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , Languedoc Roussillon , Midi Pyrées , South Korea , Benjamin Lehari , Jennifer Jullia , Drug Administration , European Medicines Agency , Group Universal Registration Document , Financial Communications , Medical Therapeutic , Artificial Intelligence , Latin American , Diagnostic Imagery , Interventional Imaging , General Meeting , Accurate Medical Therapeutics , Corporate Social Responsibility , Euronext Paris , Universal Registration Document , Globe Newswire ,